CreativeOne Wealth’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.9M Buy
29,421
+16,720
+132% +$1.18M 0.04% 366
2025
Q4
$855K Sell
12,701
-1,096
-8% -$73.7K 0.02% 616
2025
Q3
$1.01M Sell
13,797
-2,762
-17% -$183K 0.02% 548
2025
Q2
$861K Sell
16,559
-1,097
-6% -$62.4K 0.02% 583
2025
Q1
$1.13M Sell
17,656
-727
-4% -$42.2K 0.03% 443
2024
Q4
$879K Buy
18,383
+294
+2% +$15.1K 0.03% 510
2024
Q3
$1.04M Buy
+18,089
New +$1.04M 0.04% 427
2023
Q1
Sell
-4,744
Closed -$270K 808
2022
Q4
$270K Buy
+4,744
New +$243K 0.01% 604

Other funds holding HALO

CreativeOne Wealth's HALO Position: Q1 2026 in Review

CreativeOne Wealth increased its Halozyme (HALO) stake by 132% in Q1 2026, buying an estimated $1.18M and bringing the position to 29,421 shares worth $1.9M. The position accounts for 0.04% of the portfolio, ranked #366.

CreativeOne Wealth first reported a position in HALO in Q4 2022 and has held it in 8 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • CreativeOne Wealth held 29,421 shares of Halozyme worth $1.9M as of Q1 2026.
  • CreativeOne Wealth bought 16,720 Halozyme shares in Q1 2026, an estimated $1.18M.
  • Halozyme made up 0.04% of CreativeOne Wealth's portfolio in Q1 2026, its #366 holding.
  • CreativeOne Wealth first reported a position in Halozyme in Q4 2022 and has held it in 8 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.